Diabetes Care, Vol 15, Issue 5 632-637, Copyright © 1992 by American Diabetes Association
Elevated proinsulin levels related to islet cell antibodies in first-degree relatives of IDDM patients
GA Spinas, O Snorgaard, SG Hartling, M Oberholzer and W Berger
Department of Internal Medicine, University Hospital Basel, Switzerland.
OBJECTIVE--To assess whether proinsulin levels are elevated in first-degree
relatives of insulin-dependent diabetes mellitus (IDDM) patients and
whether there is a relationship between proinsulin levels and the
occurrence of immunological markers. RESEARCH DESIGN AND METHODS--Fasting
proinsulin concentrations were measured in 85 first-degree relatives (54
siblings, 20 parents, 11 children) of IDDM patients and in 90 age- and
weight-matched control subjects with no family history of diabetes
mellitus. RESULTS--Fasting proinsulin levels (median, 25th, and 75th
percentiles) were 8 pM (range 3.2-14 pM) in first-degree relatives and 1.7
pM (range 1.7-4 pM) in control subjects (P less than 0.0001). Proinsulin
was significantly elevated in siblings (7.2 pM, range 3.8-15 pM; P less
than 0.0001), parents (9.8 pM, range 6.4-13 pM; P less than 0.0001), and
children (6.6 pM, range 1.8-12 pM, P = 0.04) compared with control subjects
but without differences between these groups. Islet cell antibody positive
(ICA+) IDDM relatives had significantly higher proinsulin levels than ICA-
(16 pM; range 7.2-25 vs. 6.9 pM, range 3.1-12 pM; P = 0.02). There was no
difference between individuals with and without insulin autoantibodies. No
difference in proinsulin levels was observed if the relatives were
subdivided according to HLA-DR sharing with the diabetic proband.
CONCLUSIONS--Fasting proinsulin concentrations were raised not only in
siblings but also in parents and children of IDDM patients. Because
proinsulin is more elevated in ICA+ than in ICA- subjects, increased
proinsulin levels could reflect minor beta-cell damage due to previous
immunological attack.